Study of Ataluren (PTC124) in Cystic Fibrosis
Is a
Allocation Type
NA
0
Health Conditions in Trial
Intervention Model
Single Group Assignment
0
Intervention Name
Ataluren
0
Interventional Trial Phase
Phase 3
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Drug
0
Last Updated
March 25, 2020
0
Masking Type
None (Open Label)
0
Primary Completion Date
June 5, 2017
0
Trial Recruitment Size
61
0
Trial Sponsor
Clinical Trial Start Date
May 23, 2014
0
Study Completion Date
June 5, 2017
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
An Open-Label Safety and Efficacy Study for Patients With Nonsense Mutation Cystic Fibrosis Previously Treated With Ataluren (PTC124)
0
Official Website
Find more entities like Study of Ataluren (PTC124) in Cystic Fibrosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.